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Supplementary Figure 1. Identification and distribution of DNaseI footprints. a, As more DNaseI cleavages are sequenced from SKMC 
cells, individual DNaseI footprints are easier to distinguish. b, The number of DNaseI footprints identified in SKMC cells at varying DNaseI 
cleavage tag sequencing levels. c-d, The number of footprints in DHSs is higher for DHSs with more mapped DNaseI cleavages. DHSs 
from all 41 cell types were broken into deciles based on the sequencing depth of that DHS. The number of mapped DNaseI cleavages for 
DHSs in each quantile is indicated below the graph. The box-and-wisker plot shows the distribution of the number of footprints within 
















































Supplementary Figure 2. Distribution of DNaseI footprints. a, The genomic distribution of footprints found in 41 cell types in relation 
to annotated genomic features.  b, Examples of DNaseI footprints at different genomic features. 
a
b
Supplementary Figure 3. Motif density in DNaseI footprints. The density of motifs in DNaseI footprints, DHSs (but not in footprints) and 
non-hypersensitive genomic regions. Motifs are significantly enriched in footprints (Z-score = 204.22, Genome Structure Correction 












































































































Supplementary Figure 4. Association of footprint, occupancy and sequence conservation. a-b, Heatmaps showing per nucleotide 
DNaseI cleavage (left) and vertebrate conservation by phyloP (right) for USF (a) and YY1 (b) motifs within K562 DHSs ranked by tag 
density.  Green and blue indicator ticks in the middle indicate the presence of DNaseI footprints and ChIP-seq peaks, respectively, at 
putative genomic binding sites. c-d, Lowess regression of NRF1 (c) and USF (d) maximum phyloP score versus DNaseI footprinting 
occupancy (footprint occupancy score) at K562 DNaseI footprints marked by NRF1 (c) and USF (d) motifs.
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Supplementary Figure 5. Validation of footprints as potential sites of protein occupancy in vitro. a, Three genomic loci of 
varying footprint strength targeted using DNA interacting protein precipitation (DIPP). b, Schematic overview of the DIPP proto-
col. c-d, Targeted mass spectrometry measurements of the proteins enriched using the different probe sets. The AP1 protein 
c-Jun was enriched specifically using the AP1 probes (c) and MAX was enriched specifically using the MAX probe (d). e, As a nega-
















































Supplementary Figure 6. DNaseI footprints mark sites of functional in vivo protein occupancy. Heterozygous SNVs associated 
with allele-specific occupancy are significantly enriched inside footprints compared to the rest of the DHS (P < 2.2x10-16, Fisher's 
exact test). 

















TF core binding motif
Supplementary Figure 7. Stereotyped cleavage patterns for different TFs. The per-nucleotide DNaseI cleavage patterns at motif 
instances of 4 different transcription factors in adult dermal fibroblasts (NHDF-Ad). The different motif instances (rows) are randomly 
ordered. 
ccaNNagNNggc atgactca ctggNNNNNNgcca aggaaatg
























Supplementary Figure 8. Anti-correlation of conservation and DNaseI cleavage for factors with structural data.
a, Similar to Fig. 3a, the co-crystal structure of Serum Response Factor (SRF) bound to its DNA ligand is juxtaposed above the average
nucleotide-level DNaseI cleavage pattern (blue) at motif instances of SRF in DNaseI footprints. Nucleotides that are sensitive to
cleavage by DNaseI are colored as blue on the co-crystal structure. The motif logo generated from SRF DNaseI footprints is displayed
below the DNaseI cleavage pattern. Below is a randomly ordered heatmap showing the per-nucleotide DNaseI cleavage for each
motif instance of SRF in DNaseI footprints.  b, The per-base DNaseI hypersensitivity (blue) and vertebrate phylogenetic conservation
(red) for all DNaseI footprints in dermal fibroblasts matching three well annotated transcription factor motifs. The white box
indicates width of consensus motif. The number of motif occurrences within DNaseI footprints in indicated below each graph.





















































































































Supplementary Figure 9. General transcriptional activators occupy the PIC footprint. a, Mean ChIP-seq tag density for TATA-
binding protein centered on the TSS-linked footprint in K562 cells. b, Motifs associated with general transcription factors are found 
within the footprint. TRANSFAC motifs, reduced by similarity and non-overlapping instances of each motif group, were enumerated 
inside of the PIC footprint. 
Motifs within PIC footprint
(K652 cells)




























































































































































































NFYA ChIP Signal Strength
Supplementary Figure 10. Occupancy of transcription factors differs by mode of interaction with chromatin. a-d, ChIP-seq peaks of the 
factors YY1 (a), NFE2 (b), USF1 (c), and NFYA (d) were partitioned into three classes: direct (footprinted motif; yellow), indirect (no motif; 
green) and indeterminate (motif with no footprint; blue). The sum of the raw sequencing tags is displayed for each instance of a ChIP-


















































































































































Supplementary Figure 11. Distribution of indirect binding by transcription factor. Transcription factors are ordered by the percentages 
of total peaks bound indirectly (bottom). We compare our values of indirect binding to motif occurences (presumably direct binding) 
determined by Factorbook (http://www.factorbook.org) (top). ChIP-seq peaks are ordered by intensity and binned into groups of 500 
peaks (x-axis). The fraction of ChIP-seq peaks containing a discovered motif (y-axis) is plotted.  Red and green lines represent the known 
binding motif, except for TATA-binding protein, for which a TATA-box was not identified. The dotted horizontal line on the bottom plot 
represents 20% and 60% direct binding (80% and 40% indirect, respectively). Corresponding dotted lines are drawn on the Factorbook 
plots highlighting the percentage of binding sites that contain a cognate recognition site.
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Supplementary Figure 12. Distribution of direct and indirect transcription factor binding. a, The percentage of K562 ChIP-seq peaks 
bound directly in distal regions was computed for each factor. Here, we define distal as sites greater that 5 kilobases from any GENCODE 
level 1 and 2 annotated promoter. b, The enrichment of indirect ChIP-seq peaks found in promoters for transcription factors in (a). The 
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Supplementary Figure 13. Directly bound promoter elements mediate indirect transcription factor interactions. a, The number of 
overlapping indirect ChIP-seq peaks of other factors was computed for each directly bound ChIP-seq peak and represented as a 
histogram. On average, directly bound NFE2 ChIP-seq peaks overlap two indirect peaks of other factors, while Sp1 overlaps on average 







































































































































































Novel de novo derived motifs
Supplementary Figure 14. De novo motif discovery in footprints. a, Diagram of the depletion scheme used to identify novel motifs. 683 
motifs were filtered in successive order using TOMTOM with TRANSFAC, JASPAR-CORE and UniPROBE. The numbers on the arrows 
display the number of de novo motifs matched to the corresponding database. b, Pie chart annotating the partition of de novo motifs 
into known and novel motifs. c, Example consensus logos of de novo derived motifs that match TRANSFAC models. d, Example consen-







































































































low pi high pi
Supplementary Figure 15. Conservation and selection of DNaseI footprints. a, Phylogenetic conservation (red dashed) and per-base 
DNaseI hypersensitivity (blue) for all DNaseI footprints in dermal fibroblast cells matching two novel de novo-derived motifs. The white 
box indicates width of consensus motif. b,  Per-nucleotide mouse liver DNaseI cleavage patterns at occurrences of the motifs in (a) at 
DNaseI footprints identified in mouse liver. c, The average human nucleotide diversity (π, y-axis) across all motif instances within DNaseI 
footprints is plotted for each of the motif models in the TRANSFAC database (black, ordered by mean π) and for each of the novel de 
novo-derived motif models (red, ordered by mean π). Blue bar indicates the average nucleotide diversity (pi) at 4-fold degenerate coding 































AG10803 369,891,377 284,236,136 251,730 127,453,885 167,583 67,986,704 1,106,404 16,098,123 
AoAF 393,665,970 331,043,131 247,711 157,461,278 149,702 68,131,539 1,566,170 22,727,963 
CD20+ 300,895,833 240,594,387 176,008 143,218,339 74,681 55,800,743 603,190 8,277,635 
CD34+ Mobilized 287,605,852 221,098,234 206,033 119,621,324 125,354 59,782,641 902,386 13,494,265 
fBrain 247,674,296 202,264,605 282,491 145,389,927 166,439 72,393,628 1,022,782 16,300,790 
fHeart 328,340,544 264,719,957 292,700 200,606,802 149,848 77,501,676 954,914 14,276,245 
fLung 318,544,188 268,295,068 338,476 206,554,970 184,428 89,331,237 1,181,235 18,884,673 
GM06990 238,189,351 137,532,640 194,407 124,993,150 71,679 45,274,471 434,561 6,588,543 
GM12865 375,878,018 263,505,515 227,299 132,981,145 118,973 60,969,626 811,374 11,983,394 
HAEpiC 347,415,753 281,238,046 294,231 153,728,366 189,376 78,262,576 1,506,475 20,870,168 
HA-h 463,552,126 367,030,503 316,350 215,720,624 183,402 96,933,344 966,188 13,539,911 
HCF 375,266,490 289,961,235 251,268 136,811,533 158,618 69,285,351 1,057,743 15,531,256 
HCM 348,691,463 274,790,101 259,190 148,481,494 176,297 80,809,789 1,130,292 16,902,956 
HCPEpiC 305,511,987 253,925,492 304,490 166,336,755 194,361 80,354,004 1,296,454 18,684,469 
HEEpiC 472,469,677 342,975,637 326,246 170,658,884 195,205 76,649,605 1,263,648 18,866,093 
HepG2 248,320,583 168,883,956 199,174 115,287,739 73,091 35,775,390 448,678 6,938,557 
H7-hESC 401,363,495 302,050,785 491,178 236,940,779 248,021 99,574,058 1,279,454 18,940,427 
HFF 344,017,295 262,521,646 271,655 158,223,732 173,197 85,614,520 590,904 8,338,681 
HIPEpiC 333,832,037 254,744,863 331,341 179,188,377 209,537 82,901,328 1,089,936 16,510,277 
HMF 384,696,734 311,000,443 266,757 137,564,020 175,343 71,776,020 1,434,330 19,950,879 
HMVEC-dBl-Ad 292,823,995 239,063,258 194,045 124,284,025 142,138 75,710,345 1,085,741 14,936,244 
HMVEC-dBl-Neo 368,114,784 293,473,622 198,849 142,843,889 145,392 87,577,362 1,061,860 15,410,057 
HMVEC-dLy-Neo 338,875,033 270,345,138 196,251 122,494,916 132,021 67,831,113 989,626 14,367,015 
HMVEC-LLy 417,841,726 313,021,953 176,634 115,933,614 122,591 65,162,445 872,721 12,565,891 
HPAF 320,990,135 255,470,482 256,698 140,840,570 169,984 81,414,365 1,090,215 15,983,810 
HPdLF 371,416,176 304,268,872 266,670 168,672,350 156,380 73,248,071 1,404,872 20,203,519 
HPF 368,365,528 296,713,698 235,885 138,436,787 138,004 63,605,792 1,175,289 17,027,101 
HRCEpiC 284,056,343 236,736,388 307,274 155,486,022 178,791 71,906,908 1,187,325 17,124,566 
HSMM 467,134,471 367,269,086 331,104 177,231,683 215,419 94,115,944 1,668,243 23,986,641 
Th1 232,708,777 171,609,858 154,717 117,670,939 63,672 43,580,258 498,505 7,448,335 
HVMF 341,994,992 279,802,866 265,941 159,102,198 154,706 72,203,801 1,263,833 18,402,231 
IMR90 309,171,904 242,507,116 286,260 141,276,695 184,888 79,251,166 970,277 14,355,207 
K562 268,452,588 179,970,820 256,735 157,203,075 125,859 64,943,646 498,683 7,161,934 
NB4 404,801,445 323,812,091 236,509 141,522,055 119,640 62,875,330 1,049,300 15,418,984 
NH-A 307,812,903 231,589,045 280,019 148,952,898 176,271 80,278,529 977,923 14,329,589 
NHDF-Ad 300,516,213 235,650,107 296,898 151,532,500 212,841 93,354,642 1,429,399 20,950,088 
NHDF-neo 482,603,639 373,361,757 275,166 153,433,828 172,878 76,999,986 1,532,853 22,147,781 
NHLF 454,391,713 357,163,548 294,352 166,314,415 190,888 85,453,334 1,567,106 22,751,625 
SAEC 296,719,796 243,838,476 291,390 159,165,382 184,542 72,503,786 1,256,188 18,742,067 
SKMC 632,856,867 543,886,965 311,537 158,366,070 193,202 74,105,557 2,370,723 31,607,291 
SK-N-SH_RA 217,691,024 164,615,431 160,880 91,155,430 70,493 37,635,241 498,926 7,609,202 



















































 1,106,404 181,473 677,479  139,806 4.85
1,566,170 165,258 820,187  148,612 5.52
603,190 104,139 303,432  72,752 4.17
902,386 147,098 560,210  117,862 4.75
1,022,782 182,501 636,950  140,256 4.54
954,914 173,135 562,780  129,032 4.36
1,181,235 205,880 681,428  160,948 4.23
 434,561 92,709 195,168  49,295 3.96
 811,374 143,716 487,801  104,614 4.66
1,506,475 205,033 913,983  172,375 5.3
966,188 200,014 506,977  134,600 3.77
1,057,743 174,667 647,025  135,144 4.79
1,130,292 193,375 696,405  146,587 4.75
 1,296,454 210,380 826,565  167,674 4.93
1,263,648 209,838 834,743  173,806 4.8
448,678 90,775 228,280  54,600 4.18
1,279,454 266,618 808,678  189,181 4.27
590,904 192,282 384,995  106,555 3.61
1,089,936 225,744 731,881  164,569 4.45
1,434,330 190,512 874,301  162,132 5.39
1,085,741 162,593 644,136  123,503 5.22
 1,061,860 168,436 633,452  124,918 5.07
989,626 153,107 603,547  120,801 5
872,721 144,886 550,573  111,126 4.95
1,090,215 188,071 684,069  140,068 4.88
1,404,872 171,349 785,700  147,294 5.33
1,175,289 154,397 683,890  131,805 5.19
1,187,325 192,147 723,271  146,937 4.92
1,668,243 228,282 937,370  184,856 5.07
498,505 84,201 220,748  53,494 4.13
1,263,833 170,340 688,248  137,947 4.99
970,277 199,752 646,563  139,353 4.64
498,683 142,986 305,128  72,048 4.24
1,049,300 143,838 588,282  117,445 5.01
977,923 191,510 601,546  130,914 4.59
1,429,399 230,696 891,028  179,529 4.96
1,532,853 187,962 840,887  160,662 5.23
1,567,106 206,254 896,218  173,139 5.18
1,256,188 198,442 791,686  160,216 4.94
2,370,723 205,493 1,230,494  198,952 6.18
498,926 89,968 259,755  61,111 4.25




















































Probe ID IDT Sequence
/5BiosG/CTGGAGACTTGCAGGGTGGACAGACACACGTGGGGAAGGTTCCCGCTGCACACAACTCAACTCTGACCTG
MAX Specific R CAGGTCAGAGTTGAGTTGTGTGCAGCGGGAACCTTCCCCACGTGTGTCTGTCCACCCTGCAAGTCTCCAG
MAX Shuffled F /5BiosG/CTGGAGACTTGCAGGGTGGACAGACACAGTTCAGAGCGGCCGTGGCTGCACACAACTCAACTCTGACCTG
MAX Shuffled R CAGGTCAGAGTTGAGTTGTGTGCAGCCACGGCCGCTCTGAACTGTGTCTGTCCACCCTGCAAGTCTCCAG
AP1 Site 1 Specific F /5BiosG/CATCTGGGCACACACCCTAAGCCTCAGCATGACTCATCATGACTCAGCATTGCTGTGCTTGAGCCAGAAG
AP1 Site 1 Specific R CTTCTGGCTCAAGCACAGCAATGCTGAGTCATGATGAGTCATGCTGAGGCTTAGGGTGTGTGCCCAGATG
AP1 Site 1 Shuffled F /5BiosG/CATCTGGGCACACACCCTAAGCCTTGCAACCGGACAACAAGCGCCTTATTTTCTGTGCTTGAGCCAGAAG
AP1 Site 1 Shuffled R CTTCTGGCTCAAGCACAGAAAATAAGGCGCTTGTTGTCCGGTTGCAAGGCTTAGGGTGTGTGCCCAGATG
AP1 Site 2 Specific F /5BiosG/TGGGATTATCAGGCTGGAGTTCTCTGTCATTAGGATGACTCATCATTTTTCTATCTCTGCTTCCATTGCT
AP1 Site 2 Specific R AGCAATGGAAGCAGAGATAGAAAAATGATGAGTCATCCTAATGACAGAGAACTCCAGCCTGATAATCCCA
AP1 Site 2 Shuffled F /5BiosG/TGGGATTATCAGGCTGGAGTTCTCTGTAGTATATTCCTCATATTCTTGAGCTATCTCTGCTTCCATTGCT
AP1 Site 2 Shuffled R AGCAATGGAAGCAGAGATAGCTCAAGAATATGAGGAATATACTACAGAGAACTCCAGCCTGATAATCCCA
Supplementary Table 3. Sequence oligos used for DIPP.
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Supplementary Table 4. Complete Genomics genome sequence IDs.
